Top Markets
Coin of the day
Fresenius SE & Co. KGaA Fresenius SE & Co. KGaA

Fresenius SE & Co. KGaA

FSNUY
Rang in Aktien #183
Fresenius SE & Co. KGaA, a health care company, provides products and services... Fresenius SE & Co. KGaA, a health care company, provides products and services for dialysis, hospitals, and outpatient medical care. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, hemodialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of therapy and care ill patients. This segment offers IV drugs, including intravenously administered generic drugs for oncology, anesthetics, analgesics, anti-infectives, and critical care; parenteral and enteral nutrition products; infusion solutions and blood volume substitutes for infusion therapy; biosimilars, a biological medicine for autoimmune and oncology diseases; medical devices and disposal used to administer IV generic drugs, infusion therapies, and clinical nutrition products; and transfusion products for collection of blood components and corporeal therapies. The Fresenius Helios segment operates 90 hospitals, approximately 130 outpatient clinics, and 6 prevention centers in Germany; and 49 hospitals, 88 outpatient clinics, and approximately 300 risk prevention centers in Spain. This segment also provides services in the field of fertility treatments through 33 clinics and additional 39 sites across 10 countries on 3 continents. The Fresenius Vamed segment manages projects and offers services for hospitals and other health care facilities. This segment provides project development, planning, and turnkey construction services, as well as maintenance, technical management, and operational management services. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.
Aktienkurs
$12.65
Marktkapitalisierung
$114.00B
Veränderung (1 Tag)
1.36%
Veränderung (1 Jahr)
3.52%
Land
DE
Handel Fresenius SE & Co. KGaA (FSNUY)

Kategorie

Gewinn für Fresenius SE & Co. KGaA (FSNUY)
Gewinn im Mar 2026 TTM: $2.56B
Laut den aktuellen Finanzberichten von Fresenius SE & Co. KGaA betragen die aktuellen Gewinne des Unternehmens $2.56B. Im Jahr 2023 erzielte das Unternehmen einen Gewinn von $790.41M, ein Rückgang im Vergleich zu dem Gewinn im Jahr 2022, der $3.02B betrug. Die auf dieser Seite angezeigten Gewinne sind die Gewinne vor Zinsen und Steuern, auch bekannt als EBIT.
Gewinnverlauf von Fresenius SE & Co. KGaA von 2002 bis 2026
Gewinn am Ende jedes Jahres
Jahr Gewinn ändert
2026 (TTM) $2.56B 77.12%
2024 $1.44B 82.73%
2023 $790.41M -73.81%
2022 $3.02B -25.42%
2021 $4.05B -10.81%
2020 $4.54B 3.39%
2019 $4.39B -18.11%
2018 $5.36B 13.43%
2017 $4.73B 19.92%
2016 $3.94B 11.25%
2015 $3.54B 16.54%
2014 $3.04B -8.18%
2013 $3.31B 4.95%
2012 $3.15B 26.11%
2011 $2.50B 4.74%
2010 $2.39B 15.41%
2009 $2.07B 33.27%
2008 $1.55B 0.00%
2007 0.00 0.00%
2006 0.00 0.00%
2005 0.00 0.00%
2004 0.00 -100.00%
2003 $669.93M 16.93%
2002 $572.95M 0.00%
Gewinn ähnlicher Unternehmen oder Konkurrenten
Unternehmen Gewinn Gewinnunterschied Land
$9.79B 282.77%
US
$658.38M -74.26%
SA
$3.17B 23.80%
US
$861.87M -66.31%
CN
$1.40B -45.21%
US